Dimensional Fund Advisors’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding FRTX
BI
SCM
FI
PAM
Dimensional Fund Advisors's FRTX Position: Q2 2019 in Review
Dimensional Fund Advisors sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2019, closing a stake of 36 shares — an estimated $14K sold.
Dimensional Fund Advisors first reported a position in FRTX in Q2 2013 and held it in 16 quarters. The position peaked at $770K in Q2 2013. 22 funds tracked by Wall St. Rank hold FRTX as of Q2 2019.
- Dimensional Fund Advisors reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- Dimensional Fund Advisors sold 36 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $14K.
- Dimensional Fund Advisors first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
- Dimensional Fund Advisors's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $770K in Q2 2013.
- 22 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2019.
Based on Dimensional Fund Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.